Neues vom BioCity Campus

Associations call for industrial policy support for the medical technology industry

BVMed, Spectaris and ZVEI call in a joint position paper for the strengthening of Germany as a medical technology location. With the "Target Image Medical Technology 2025", they want to give politicians recommendations for action for an overall strategy. Germany must be and remain a strong medical technology location," explain the three medical technology industry associations BVMed, Spectaris and ZVEI in their joint "Target Image Medical Technology 2025". The demands include an interdepartmental and strategic "medtech dialogue" based on other industry dialogues in order to jointly consider health, economic and research policy aspects.

Recommendations for action for politicians

"Medical technology must and wants to be powerful, and there has been no doubt about that since the latest pandemic experience at the latest. With our target image for 2025, we are not only giving politicians the necessary recommendations for reform policy action, but are also appealing across associations and urgently for joint action to be taken in the coming legislature," the three associations emphasise.

Implementing structural reforms

The trade associations will show a total of five fields of action along the value chain for an innovative, economically healthy and internationally competitive German medical technology industry in 2025 and beyond. This requires coordinated industrial policy support from the industry in order to tackle structural reforms: separate departmental responsibilities for health, research and business have so far prevented an overall political strategy for medical technology. Their complex concerns in the areas of research and development, regulation, production and market access are too often lost.

Promoting dialogue, digitalisation and research

In addition to a strategic medtech dialogue involving the three Federal Ministries of Economics, Research and Health, the associations are also proposing a digital inventory platform for supply-critical medical devices, better promotion of clinical studies and access for companies to health research data. "Research and production must continue to be possible for medium-sized medical technology companies in Germany. To this end, we need to strengthen the production and supply chains and develop smart solutions involving the medtech industry," says BVMed Managing Director Dr. Marc-Pierre Möll.

Make better use of digital health data

The associations see particular potential in digitalization: "The digital possibilities in medical technology must also be more strongly integrated into the German healthcare industry," says Hans-Peter Bursig, ZVEI's Managing Director for Electromedical Technology. "We must create the conditions for a health data space, ensure integration into the European Health Data Space and thus achieve legally secure access to this data for industry as well." Anonymized health data for commercial research, development and innovation played an increasingly important role.

Regulatory requirements must not weaken location

The associations also see that manufacturing processes and market access in the EU are becoming increasingly complex for medical technology due to increasing regulatory requirements: "The medical technology industry has to contend with a flood of regulations that has been increasing for years, not least due to the Medical Device Regulation (MDR), whose bureaucratic additional effort does not always contribute to additional patient safety. This trend must be countered with the political will to measure each new regulation by its impact on the competitiveness and innovative capacity of our high-tech industry," emphasizes Dr. Martin Leonhard, Chairman of Medical Technology at the German Industry Association Spectaris. The aim must be to permanently strengthen Germany as a location for the medical technology industry. The presentation of the target image is the prelude to a political discourse that will be continued and intensified in the next legislative period.

To the target image medical technology 2025:

Source: Communication medizin&technik of 09.06.2021

Previous News

biosaxony: An industry takes stock – Saxon biotech solutions in the fight against the corona pandemic

The industry association biosaxony e. V. will launch a digital campaign on 22 June 2021 to honour the commitment of Saxon biotech and medtech companies.

Next News

Co. DON AG: GMP inspection of the higher federal authority and the state directorate of Saxony at the Leipzig site successfully completed

Last week, the inspection of the new production plant by the higher federal authority Paul-Ehrlich-Institut (PEI) and the state authority of Saxony took place at the Leipzig site. The content of the inspection was the implementation of the GMP guidelines imposed by the health authorities.